These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 23815025)

  • 21. The costs of heart failure in Poland from the public payer's perspective. Polish programme assessing diagnostic procedures, treatment and costs in patients with heart failure in randomly selected outpatient clinics and hospitals at different levels of care: POLKARD.
    Czech M; Opolski G; Zdrojewski T; Dubiel JS; Wizner B; Bolisęga D; Fedyk-Łukasik M; Grodzicki T
    Kardiol Pol; 2013; 71(3):224-32. PubMed ID: 23575775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Healthcare utilization and expenditures in patients with atrial fibrillation treated with catheter ablation.
    Ladapo JA; David G; Gunnarsson CL; Hao SC; White SA; March JL; Reynolds MR
    J Cardiovasc Electrophysiol; 2012 Jan; 23(1):1-8. PubMed ID: 21777324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Future financing of health care.
    Bailit HL
    J Dent Educ; 1986 Feb; 50(2):119-24. PubMed ID: 3080506
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative cost analysis of outpatient and inpatient rehabilitation for cardiac diseases].
    Zeidler J; Mittendorf T; Vahldiek G; von der Schulenburg JM
    Herz; 2008 Sep; 33(6):440-7. PubMed ID: 19156379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost containment: Europe. Germany.
    Burchardi H; Schuster HP; Zielmann S
    New Horiz; 1994 Aug; 2(3):364-74. PubMed ID: 8087598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reform of the health care service system in Israel 1995-2000.
    Hart J
    World Hosp Health Serv; 2001; 37(3):9-11, 40, 42. PubMed ID: 11858011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of diabetes mellitus on healthcare costs in Italy.
    Giorda CB; Manicardi V; Diago Cabezudo J
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):709-19. PubMed ID: 22098288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economy, costs and funding: key issues for Canada's health care system.
    Rea PA; Tregunna K
    Leadersh Health Serv; 1992; 1(4):33-6. PubMed ID: 10123136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustainability of recurrent expenditure on public social welfare programmes: expenditure analysis of the free maternal care programme of the Ghana National Health Insurance Scheme.
    Ankrah Odame E; Akweongo P; Yankah B; Asenso-Boadi F; Agyepong I
    Health Policy Plan; 2014 May; 29(3):271-9. PubMed ID: 23543198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefit-incidence analysis of government spending on Ministry of Health outpatient services in Jordan.
    Halasa Y; Nassar H; Zaky H
    East Mediterr Health J; 2010 May; 16(5):467-73. PubMed ID: 20799544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Public and private donor financing for health in developing countries.
    Howard LM
    Infect Dis Clin North Am; 1991 Jun; 5(2):221-34. PubMed ID: 1869807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic cost of Guillain-Barré syndrome in the United States.
    Frenzen PD
    Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Finance for health care: part of a broad canvas.
    Evlo K; Carrin G
    World Health Forum; 1992; 13(2-3):165-70. PubMed ID: 1418329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [National Health Insurance expenditures in 1994 for thirty long-term illness].
    Fender P; Païta M; Salanave B; Ganay D; Allemand H
    Sante Publique; 2000 Mar; 12(1):5-19. PubMed ID: 10850139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interventional pain management at crossroads: the perfect storm brewing for a new decade of challenges.
    Manchikanti L; Singh V; Boswell MV
    Pain Physician; 2010; 13(2):E111-40. PubMed ID: 20309388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmaceutical management strategies of industrialized countries.
    Brier KL
    Formulary; 1995 Oct; 30(10):606-10, 614. PubMed ID: 10151724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does public insurance provide better financial protection against rising health care costs for families of children with special health care needs?
    Yu H; Dick AW; Szilagyi PG
    Med Care; 2008 Oct; 46(10):1064-70. PubMed ID: 18815528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Assessment of annual health insurance reimbursement for oncology drugs in Hungary].
    Boncz I; Donkáné Verebes E; Oberfrank F; Kásler M
    Magy Onkol; 2010 Dec; 54(4):283-8. PubMed ID: 21163758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Forecasts of the costs of medical care for persons with HIV: 1992-1995.
    Hellinger FJ
    Inquiry; 1992; 29(3):356-65. PubMed ID: 1356925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Significant increase in health insurance contributions. Where does the 7 billion euro extra income go?].
    Stoschek J
    MMW Fortschr Med; 2007 Jan; 149(1-2):52-3. PubMed ID: 17619369
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.